Newspapers / The Front Page (Raleigh, … / June 23, 2000, edition 1 / Page 9
Part of The Front Page (Raleigh, N.C.) / About this page
This page has errors
The date, title, or page description is wrong
This page has harmful content
This page contains sensitive or offensive material
WHAT YOUR PROTEASE INHIBITOR CAN BE: FILM COATED TABLETS NOW AVAILABLE 0tart therapy VIRACEPT is tough on HIV. In many people, VIRACEPT lowered the amount of HIV in the blood to levels below the limit of detection of the test used and substantially increased CD4 cell counts Things you should know about VIRACEPT VIRACEPT is generally well tolerated. People treated with VIRACEPT may experience some side effects; the most common is diarrhea. Diarrhea of moderate or severe after 48 weeks of triple combination therapy. Qake your medicine VIRACEPT is easy to live with. Take it two or three times a day (according to your doctor's instructions) with your normal meals or light snacks. Qvery dose. Every day.™ VIRACEPT works. It is indicated for the treatment of HIV infection when anti-HIV drug therapy is warranted. It is VI RACE FT nelfinavir mesylate tablets and oral powder NOW VIRACEPT MAY BE TAKEN TWICE A DAY intensity occurred in about one out ot five people in clinical trials. Some common medications and some HIV related medications should not be taken with VIRACEPT. Protease inhibitors, including VIRACEPT, may interact with cholesterol lowering drugs. Talk to your doctor about any prescription or non-prescription drugs you are not yet known whether taking VIRACEPT will help you live longer or reduce the number of infections or other illnesses that can occur with HIV. Ulan ahead Learn how your treatment plan helps you fight HIV. Take an active role in designing your treatment plan along with your healthcare provider. Ask your doctor, nurse, or pharmacist how VIRACEPT can be part of your strategy for long-term management of HIV. taking. For some people, protease inhibitors have been associated with the onset or worsening of diabetes mellitus and hyperglycemia, changes in the distribution or accumulation of body fat, and increased bleeding in patients with hemophilia. For more information, call toll free 1-888 VIRACEPT or visit www.viracept.com. (Refer to the important information on the next page.) *IMS Health National Prescription Audit™ data for Pis and NNRTIs, 01/00-03/00. VIRACEPT and Agouron are registered trademarks of Agouron Pharmaceuticals, Inc. 1-V00033-AP Copyright © 2000 Agouron Pharmaceuticals, Inc. All rights reserved. Agouron Pharmaceuticals, ha
The Front Page (Raleigh, N.C.)
Standardized title groups preceding, succeeding, and alternate titles together.
June 23, 2000, edition 1
9
Click "Submit" to request a review of this page. NCDHC staff will check .
0 / 75